{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T07:43:08Z","timestamp":1792222988131,"version":"4.4.0"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejcancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.ejca.2026.117787","type":"journal-article","created":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T23:31:26Z","timestamp":1792020686000},"page":"117787","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Systemic inflammation and patient-reported quality of life as combined prognosticators in patients with solid tumors"],"prefix":"10.1016","volume":"248","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-9151-4139","authenticated-orcid":false,"given":"Vincent","family":"Sunder-Plassmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8920-0206","authenticated-orcid":false,"given":"Philipp","family":"Melhorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5867-8461","authenticated-orcid":false,"given":"Angelika Martina","family":"Starzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia Maria","family":"Berger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0174-7889","authenticated-orcid":false,"given":"Lynn","family":"Gottmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Korpan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Kleinberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabella Solano","family":"Henao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josef","family":"F\u00fcrst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikola","family":"Vladic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2607-9717","authenticated-orcid":false,"given":"Cihan","family":"Ay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanja","family":"Stamm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3541-2315","authenticated-orcid":false,"given":"Matthias","family":"Preusser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerwin","family":"Heller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Sophie","family":"Berghoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ejca.2026.117787_bib1","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/s41392-024-01856-7","article-title":"Exploring treatment options in cancer: tumor treatment strategies","volume":"9","author":"Liu","year":"2024","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"10.1016\/j.ejca.2026.117787_bib2","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/s41392-024-01823-2","article-title":"Tumor biomarkers for diagnosis, prognosis and targeted therapy","volume":"9","author":"Zhou","year":"2024","journal-title":"Signal Transduct Target Ther"},{"issue":"6","key":"10.1016\/j.ejca.2026.117787_bib3","doi-asserted-by":"crossref","DOI":"10.1097\/00000421-198212000-00014","article-title":"Toxicity and response criteria of the Eastern Cooperative Oncology Group","volume":"5","author":"Oken","year":"1982","journal-title":"Am J Clin Oncol"},{"issue":"3","key":"10.1016\/j.ejca.2026.117787_bib4","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1038\/clpt.2011.122","article-title":"Use of Inflammatory Markers to Guide Cancer Treatment","volume":"90","author":"Clarke","year":"2011","journal-title":"Clin Pharmacol & Ther"},{"issue":"2","key":"10.1016\/j.ejca.2026.117787_bib5","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/sj.bjc.6602922","article-title":"Evaluation of an inflammation-based prognostic score (GPS) in patients with metastatic breast cancer","volume":"94","author":"Murri","year":"2006","journal-title":"Br J Cancer"},{"issue":"1","key":"10.1016\/j.ejca.2026.117787_bib6","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/cam4.4940","article-title":"A comprehensive analysis of Glasgow Prognostic Score (GPS)\/the modified Glasgow Prognostic Score (mGPS) on immune checkpoint inhibitor efficacy among patients with advanced cancer","volume":"12","author":"Zhang","year":"2023","journal-title":"Cancer Med"},{"issue":"17","key":"10.1016\/j.ejca.2026.117787_bib7","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1016\/j.ejca.2011.03.028","article-title":"A comparison of inflammation-based prognostic scores in patients with cancer. A Glasgow Inflammation Outcome Study","volume":"47","author":"Proctor","year":"2011","journal-title":"Eur J Cancer"},{"issue":"4","key":"10.1016\/j.ejca.2026.117787_bib8","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1038\/sj.bjc.6606087","article-title":"An inflammation-based prognostic score (mGPS) predicts cancer survival independent of tumour site: a Glasgow Inflammation Outcome Study","volume":"104","author":"Proctor","year":"2011","journal-title":"Br J Cancer"},{"issue":"11","key":"10.1016\/j.ejca.2026.117787_bib9","doi-asserted-by":"crossref","first-page":"e493","DOI":"10.1016\/S1470-2045(14)70263-3","article-title":"Cancer-related inflammation and treatment effectiveness","volume":"15","author":"Diakos","year":"2014","journal-title":"Lancet Oncol"},{"issue":"3","key":"10.1016\/j.ejca.2026.117787_bib10","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1017\/S0029665108007131","article-title":"An inflammation-based prognostic score and its role in the nutrition-based management of patients with cancer: nutrition society and BAPEN Medical Symposium on \u2018Nutrition support in cancer therapy","volume":"67","author":"McMillan","year":"2008","journal-title":"Proc Nutr Soc"},{"issue":"5","key":"10.1016\/j.ejca.2026.117787_bib11","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/jnci\/85.5.365","article-title":"The European organization for research and treatment of cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology","volume":"85","author":"Aaronson","year":"1993","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ejca.2026.117787_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2025.103153","article-title":"Prognostic value of baseline EORTC QLQ-C30 scores for overall survival across 46 clinical trials covering 17 cancer types: a validation study","volume":"82","author":"Lim","year":"2025","journal-title":"eClinicalMedicine"},{"issue":"8","key":"10.1016\/j.ejca.2026.117787_bib13","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1200\/JCO.2007.13.3439","article-title":"The Prognostic Significance of Patient-Reported Outcomes in Cancer Clinical Trials","volume":"26","author":"Gotay","year":"2008","journal-title":"J Clin Oncol"},{"issue":"13","key":"10.1016\/j.ejca.2026.117787_bib14","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1200\/JCO.2010.33.4631","article-title":"Relationship Between Deficits in Overall Quality of Life and Non\u2013Small-Cell Lung Cancer Survival","volume":"30","author":"Sloan","year":"2012","journal-title":"J Clin Oncol"},{"issue":"12","key":"10.1016\/j.ejca.2026.117787_bib15","doi-asserted-by":"crossref","first-page":"3131","DOI":"10.1002\/1097-0142(19910615)67:12<3131::AID-CNCR2820671232>3.0.CO;2-4","article-title":"Quality of life assessment. An independent prognostic variable for survival in lung cancer","volume":"67","author":"Ganz","year":"1991","journal-title":"Cancer"},{"issue":"9","key":"10.1016\/j.ejca.2026.117787_bib16","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1634\/theoncologist.2013-0120","article-title":"The systemic inflammatory response and its relationship to pain and other symptoms in advanced cancer","volume":"18","author":"Laird","year":"2013","journal-title":"Oncologist"},{"issue":"9","key":"10.1016\/j.ejca.2026.117787_bib17","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1016\/j.cell.2023.03.028","article-title":"Cachexia: a systemic consequence of progressive, unresolved disease","volume":"186","author":"Ferrer","year":"2023","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.ejca.2026.117787_bib18","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s12029-021-00643-9","article-title":"Depression and anxiety among patients with cancer during COVID-19 pandemic: a systematic review and meta-analysis","volume":"52","author":"Ayubi","year":"2021","journal-title":"J Gastrointest Cancer"},{"issue":"19","key":"10.1016\/j.ejca.2026.117787_bib19","doi-asserted-by":"crossref","first-page":"5456","DOI":"10.1158\/1078-0432.CCR-13-1066","article-title":"Prognostic factors in patients with advanced cancer: a comparison of clinicopathological factors and the development of an inflammation-based prognostic system","volume":"19","author":"Laird","year":"2013","journal-title":"Clin Cancer Res"},{"issue":"23","key":"10.1016\/j.ejca.2026.117787_bib20","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1200\/JCO.2015.65.7742","article-title":"Quality of life in patients with advanced cancer: differential association with performance status and systemic inflammatory response","volume":"34","author":"Laird","year":"2016","journal-title":"J Clin Oncol"},{"issue":"9","key":"10.1016\/j.ejca.2026.117787_bib21","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/S1470-2045(09)70200-1","article-title":"Baseline quality of life as a prognostic indicator of survival: a meta-analysis of individual patient data from EORTC clinical trials","volume":"10","author":"Quinten","year":"2009","journal-title":"Lancet Oncol"},{"issue":"9","key":"10.1016\/j.ejca.2026.117787_bib22","first-page":"2121","article-title":"Do elderly patients with metastatic cancer have worse quality of life scores?","volume":"20","author":"Koo","year":"2012","journal-title":"Support Care Cancer"},{"issue":"8","key":"10.1016\/j.ejca.2026.117787_bib23","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1093\/annonc\/mdy228","article-title":"Addressing the quality of life needs of older patients with cancer: a SIOG consensus paper and practical guide","volume":"29","author":"Scott\u00e9","year":"2018","journal-title":"Ann Oncol"},{"issue":"6","key":"10.1016\/j.ejca.2026.117787_bib24","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.jgo.2015.09.001","article-title":"Applicability of modified Glasgow Prognostic Score in the assessment of elderly patients with cancer: A pilot study","volume":"6","author":"Lealdini","year":"2015","journal-title":"J Geriatr Oncol"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804926015698?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804926015698?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T07:29:52Z","timestamp":1792222192000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804926015698"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":24,"alternative-id":["S0959804926015698"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2026.117787","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Systemic inflammation and patient-reported quality of life as combined prognosticators in patients with solid tumors","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2026.117787","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"117787"}}